Top Markets
#1 Helium Helium +49.84%
#2 TENDIES TENDIES +37.70%
#3 Pons Pons +29.59%
#4 Seeker Seeker +20.73%
#5 UnifAI Network UnifAI Network +15.18%
#6 pipedog pipedog +13.53%
#7 Songbird Songbird +12.18%
#8 StonkBroker StonkBroker +11.81%
#9 OSK OSK +9.95%
#10 Lista DAO Lista DAO +9.95%
Coin of the day
Helium Helium
Settings
Language
ENGLISH
Currency
USD
Theme
Shanghai Haohai Biological Technology Co., Ltd. Shanghai Haohai Biological Technology Co., Ltd.

Shanghai Haohai Biological Technology Co., Ltd.

688366
Rank in Stocks #10462
Shanghai Haohai Biological Technology Co., Ltd. is a global enterprise... Shanghai Haohai Biological Technology Co., Ltd. is a global enterprise specializing in the research, development, manufacturing, and distribution of advanced biomedical materials. Its operations span Mainland China, the United States, the United Kingdom, and various international markets. The company's extensive product portfolio serves multiple medical fields. For ophthalmology, offerings include intraocular lenses, ophthalmic viscoelastic devices, specialized orthokeratology and phakic refractive lenses, eye drops, injectors, and surgical scalpels. In orthopedics, they provide sodium hyaluronate injections and medical chitosan. Their wound care segment features recombinant human epidermal growth factor, effective in treating a broad spectrum of injuries, including burns, residual wounds, donor site trauma, post-traumatic wounds, and both acute and chronic ulcerations. Anti-adhesion solutions are offered in the form of medical sodium hyaluronate gel and medical chitosan, while hemostatic products include collagen sponges and porcine fibrin sealants. Within medical aesthetics, Shanghai Haohai produces a diverse range of hyaluronic acid (HA) dermal fillers: Matrifill, a first-generation mono-phase injectable gel; Janlane, a second-generation filler engineered for dynamic applications; and Hyalumatrix, a third-generation product designed for precise aesthetic enhancements. This division also supplies radio frequency devices and laser equipment. Beyond its core product offerings, the company actively pursues research and development in biological engineering and pharmaceutical innovations. It also provides related technology transfer and consultation services, alongside engaging in investment and trading activities. Originally established in 2007 as Haohai Limited, the company adopted its current name, Shanghai Haohai Biological Technology Co., Ltd., in 2010 and is headquartered in Shanghai, China.
Share Price
$4.39
Last synced: 2026-08-28
Market Cap
$835.72M
Change (1 day)
0.33%
Change (1 year)
-42.81%
Country
CN
Trade Shanghai Haohai Biological Technology Co., Ltd. (688366)

Category

Healthcare
Stock price history for Shanghai Haohai Biological Technology Co., Ltd. (688366)
Highest end of day price: $4.58 on 2026-08-01

Lowest end of day price: $12.22 on 2019-10-01
Stock price history of Shanghai Haohai Biological Technology Co., Ltd. from 2019 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -7.96%
2025 -24.84%
2024 -17.25%
2023 18.20%
2022 -39.68%
2021 38.45%
2020 20.76%
2019 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH